Fei Peng

Director Financiero/CFO en Beijing Biostar Pharmaceuticals Co. Ltd. .

50 años

Consumer Services

Health Technology

Perfil

Fei Peng is currently the Chief Financial Officer at Beijing Biostar Pharmaceuticals Co. Ltd.
He graduated from Southwestern University of Finance & Economics with an undergraduate degree in 2006.

Cargos activos de Fei Peng

Empresas	Cargo	Inicio
Beijing Biostar Pharmaceuticals Co. Ltd. Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China.	Director Financiero/CFO	07/03/2022

Todos los cargos activos de Fei Peng

Formación de Fei Peng.

Southwestern University of Finance & Economics

Undergraduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Fei Peng.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	1
Beijing Biostar Pharmaceuticals Co. Ltd. Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China.	Health Technology